# Hiroto Miwa

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/hiroto-miwa/

## Facts

| Field | Value |
| --- | --- |
| Citations | 20,669 |
| Field | Helicobacter pylori-related gastroenterology studies |
| h-index | 71 |
| i10-index | 324 |
| Last Known Institution | Hyogo Medical University |
| OpenAlex ID | https://openalex.org/A5022159060 |
| ORCID iD | 0000-0001-9844-642X |
| Works | 760 |

## Researcher papers

Showing 12 of 17.

- [Molecular cloning, expression, and gene localization of a fourth melanocortin receptor](https://scholariq.org/papers/molecular-cloning-expression-and-gene-localization-of-a-fourth-melanocortin/)
- [Molecular cloning of a novel melanocortin receptor.](https://scholariq.org/papers/molecular-cloning-of-a-novel-melanocortin-receptor/)
- [Lapatinib Plus Paclitaxel Versus Paclitaxel Alone in the Second-Line Treatment of <i>HER2</i>-Amplified Advanced Gastric Cancer in Asian Populations: TyTAN—A Randomized, Phase III Study](https://scholariq.org/papers/lapatinib-plus-paclitaxel-versus-paclitaxel-alone-in-the-second-line-treatment/)
- [Esophageal Disorders](https://scholariq.org/papers/esophageal-disorders/)
- [Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naïve patients with advanced gastric cancer](https://scholariq.org/papers/phase-iii-study-comparing-oxaliplatin-plus-s-1-with-cisplatin-plus-s-1-in/)
- [Evidence-based clinical practice guidelines for inflammatory bowel disease 2020](https://scholariq.org/papers/evidence-based-clinical-practice-guidelines-for-inflammatory-bowel-disease-2020/)
- [Evidence-based clinical practice guidelines for Liver Cirrhosis 2020](https://scholariq.org/papers/evidence-based-clinical-practice-guidelines-for-liver-cirrhosis-2020/)
- [Phase III Trial Comparing Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1 in Patients With Gastric Cancer With Peritoneal Metastasis: PHOENIX-GC Trial](https://scholariq.org/papers/phase-iii-trial-comparing-intraperitoneal-and-intravenous-paclitaxel-plus-s-1/)
- [Molecular Cloning, Expression, and Characterization of a Fifth Melanocortin Receptor](https://scholariq.org/papers/molecular-cloning-expression-and-characterization-of-a-fifth-melanocortin/)
- [Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015](https://scholariq.org/papers/evidence-based-clinical-practice-guidelines-for-gastroesophageal-reflux-disease/)
- [Gastrointestinal mucosal barrier function and diseases](https://scholariq.org/papers/gastrointestinal-mucosal-barrier-function-and-diseases/)
- [Potent Potassium-competitive Acid Blockers: A New Era for the Treatment of Acid-related Diseases](https://scholariq.org/papers/potent-potassium-competitive-acid-blockers-a-new-era-for-the-treatment-of-acid/)

## Researcher topics

- [Helicobacter pylori-related gastroenterology studies](https://scholariq.org/topics/helicobacter-pylori-related-gastroenterology-studies/)
- [Gastrointestinal motility and disorders](https://scholariq.org/topics/gastrointestinal-motility-and-disorders/)
- [Gastroesophageal reflux and treatments](https://scholariq.org/topics/gastroesophageal-reflux-and-treatments/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Eosinophilic Esophagitis](https://scholariq.org/topics/eosinophilic-esophagitis/)

## Researcher university

- [Hyogo Medical University](https://scholariq.org/institutions/hyogo-medical-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.